BioCardia to Present at 2015 Stem Cell Meeting on the Mesa

October 06, 2015

SAN CARLOS, CA (GlobeNewswire) – BioCardia, Inc., a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases announced today that Peter Altman, Chief Executive Officer will present at the annual Partnering Forum of the Stem Cell Meeting on the Mesa to be held October 7-9 in La Jolla, California.

Event:

2015 Stem Cell Meeting on the Mesa – Partnering Forum

Date

October 07, 2015

Time

1:30 p.m. PDT

Location

Estancia La Jolla Hotel & Spa
9700 North Torrey Pines Road, La Jolla, CA 92037

A live video webcast will be available here. Please visit this site for full information.

This conference brings together senior executives and top decision makers in the industry within the scientific community with the shared goal of advancing and translating cutting-edge research into revolutionary treatments and cures.


About BioCardia, Inc.
BioCardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its CardiAMP™ and CardiALLO™ cell therapies. Clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with intramyocardial delivery of marrow-derived cells. These programs are enabled by the Company's Helix™ transendocardial delivery systems and Morph® vascular access products, which are partnered to enable other promising biotherapeutic programs.

Contact:
Miranda Peto Benvenuti MPeto@BioCardia.com

News


Have questions?
CALL US NOW
: (800) 624-1179
Have questions?
EMAIL US NOW
: info@biocardia.com

biocardia takes a new and comprehensive
approach to heart failure

By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.